Results 71 to 80 of about 18,468 (169)

Tetanus immunity in 50 Years of Age and Older Persons in Kashan

Sālmand, 2011
Ojectives: Tetanus is a neurologic disorder which occurs as sporadic cases in people with incomplete vaccination course.The most tetanus patients are people over 60 years of age.It is a important disease in elderly patients because of risk of severe ...
Reza Razaghi, Ahmad Khalife Soltani, Mansoureh Momen Heravi   +2 more
doaj  

Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan

Bulletin of the World Health Organization, 2004
OBJECTIVE: This study aimed to estimate the incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in the Loralai district of Pakistan.
Ulla K. Griffiths, Lara J. Wolfson, Arshad Quddus, Mohammed Younus, Rehan A. Hafiz   +4 more
doaj  

KNOWLEDGE ATTITUDE AND PRACTICES REGARDING TETANUS TOXOID VACCINATION IN REPRODUCTIVE AGE WOMEN (15-49). A DESCRIPTIVE CROSSSECTIONAL STUDY IN PAK EMIRATES MILITARY HOSPITAL, RAWALPINDI

Pakistan Armed Forces Medical Journal, 2019
Background: Tetanus infection caused by bacterium Clostridium tetani is a non-communicable and preventable cause of morbidity and mortality in neonates.
Dr.Komal Bint e Ajmal, Dr.Naila Azam, Dr. Farrah Pervaiz, Dr.Syeda Shehirbano Akhtar, Dr. Humaira Mahmood, Dr. Sehar Yousaf   +5 more
doaj   +2 more sources

A minority of proliferating human CD4+ T cells in antigen-driven proliferation assays are antigen specific

Frontiers in Immunology
Antigen-driven T-cell proliferation is often measured using fluorescent dye dilution assays, such as the CFSE-based proliferation assay. Dye dilution assays have been powerful tools to detect human CD4+ T-cell responses, particularly against autoantigens.
Pushpak Bhattacharjee, Miha Pakusch, Matthew Lacorcia, Chris Y. Chiu, Xin Liu, Xin Liu, Eleonora Tresoldi, Abby Foster, Laura King, Fergus J. Cameron, Fergus J. Cameron, Fergus J. Cameron, Stuart I. Mannering, Stuart I. Mannering, Stuart I. Mannering, Stuart I. Mannering, Stuart I. Mannering   +16 more
doaj   +1 more source

Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines. [PDF]

Vaccines (Basel), 2023
Oldrini D, Di Benedetto R, Carducci M, De Simone D, Massai L, Alfini R, Galli B, Brunelli B, Przedpelski A, Barbieri JT, Rossi O, Giannelli C, Rappuoli R, Berti F, Micoli F.   +14 more
europepmc   +1 more source

Problems of tetanus prevention in adults

Эпидемиология и вакцинопрофилактика
Relevance. As a result of more than 90% coverage of the population with tetanus immunization in Russia, the incidence of this disease has decreased almost 100 times compared to the pre-vaccination period. Nevertheless, over the past decade, 8-19 cases of
L. V. Rubis
doaj   +1 more source

Validation of Free Formaldehyde Determination Method in DT Vaccine and Tetanus Toxoid Antigen. [PDF]

Arch Razi Inst, 2023
Zali S, Es-Haghi A, Ranjbar Rafie H.
europepmc   +1 more source

Adjuvant Effect of Whole-Cell Pertussis Component on Tetanus Toxoid Potency in Murine Model. [PDF]

Biomedicines, 2023
Prygiel M, Mosiej E, Wdowiak K, Rabczenko D, Zasada AA.   +4 more
europepmc   +1 more source

Engineering of tetanus toxoid-loaded polymeric microneedle patches. [PDF]

Drug Deliv Transl Res, 2023
Arshad MS, Gulfam S, Zafar S, Jalil NA, Ahmad N, Qutachi O, Chang MW, Singh N, Ahmad Z.   +8 more
europepmc   +1 more source

Annual two-dose tetanus toxoid vaccination induces protective humoral immunity to all age groups of rhesus macaques. [PDF]

Exp Anim, 2023
Murata M, Kovba A, Kaneko A, Morimoto M, Ishigami A, Natsume T, Washizaki A, Miyabe-Nishiwaki T, Suzuki J, Akari H.   +9 more
europepmc   +1 more source